%0 Journal Article
%A Blocka, Joanna
%A Hielscher, Thomas
%A Mueller-Tidow, Carsten
%A Goldschmidt, Hartmut
%A Hillengass, Jens
%T Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy.
%J Leukemia and lymphoma
%V 61
%N 1
%@ 1029-2403
%C London [u.a.]
%I Taylor & Francis Group
%M DKFZ-2019-02014
%P 27-36
%D 2020
%Z  2020 Jan;61(1):27-36
%X It is a matter of debate whether myeloma patients with progressive disease (PD) after induction should receive salvage therapy or proceed directly to autologous stem cell transplantation. We performed a retrospective analysis of 1599 patients treated between 1991 and 2016 at the University Hospital of Heidelberg and other centers. Deepening of response through salvage therapy did not lead to better progression-free or overall survival (PD versus salvage therapy patients: HR = 0.71, 95
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31423866
%R 10.1080/10428194.2019.1646905
%U https://inrepo02.dkfz.de/record/144571